Venture-Backed Startups

BioDigital operates the BioDigital Human, an interactive 3D software platform for visualizing human anatomy, physiology, disease, and treatment. It serves medical educators, clinical trainers, patient engagement teams, and health, medical, and life science organizations that embed customizable 3D visualizations into their digital channels, LMS, or curricula across web, mobile, and AR/VR.

2 investors

Biodimension operates a biofabrication platform that builds reconstructed human tissues, patient-derived organoids, and 3D disease models from ethically sourced human cells for non-animal (NAMs) testing. Its models serve drug discovery, cosmetic safety, and regenerative medicine teams needing regulatory-aligned efficacy and toxicity data without animal testing, from a facility in Bengaluru, India.

1 investor

0 investors

BioDit offers biometric security solutions, including wireless and wired systems for access control and identity verification.

2 investors

The Biodiversity Council is an Australian organization that works with scientists, communities, Traditional Owners, farmers, government and industry to address biodiversity decline in Australia. It produces research, policy submissions and public resources, and relies on donations and partner funding.

1 investor

Biodiversity Intelligence measures and monitors biodiversity by combining eDNA sampling of soil and water, satellite and SAR remote sensing, climate data, and deep learning to produce standardized nature indices and indicators. It targets nature-market and land-use project operators, supporting nature disclosure, certification, and nature-based solutions through an interactive monitoring dashboard.

1 investor

Biodlink is a contract development and manufacturing organization (CDMO) focused on biologics, including monoclonal antibody drug substances and antibody-drug conjugates (ADCs). It provides drug development and commercial-scale manufacturing services with capacity for monoclonal antibody and ADC drug substances.

1 investor

Biodock provides an AI image analysis platform designed for researchers and scientists to train, run, and interpret deep learning models on biological images without requiring coding expertise. The platform enables rapid model creation, distributed execution at scale, and detailed quantitative analysis for research organizations in biotech and life sciences.

3 investors

Biodol Therapeutics is a biotech company developing proprietary FLT3 inhibitors (BDT compounds) at the preclinical stage to treat neuropathic and chronic pain, including opioid-combination indications. It holds a portfolio of patents covering the use of FLT3 inhibitors for pain treatment.

1 investor

Provides technologies for detection, neutralization, and removal of endotoxin for bioresearch and bioprocess markets.

1 investor

Biodynamik is a medical device company developing orthopedic-driven regenerative technologies, including its XT3 System for treating diabetic foot ulcers. The company is pursuing U.S. clinical trials under FDA IDE approval.

0 investors

BioEclipse Therapeutics is a clinical-stage oncology company developing immuno-oncology therapeutics using a proprietary platform that targets the tumor microenvironment through engineered immune cell therapies. The company's approach combines multiple mechanisms of action to eradicate cancer cells and generate durable immune responses against relapse and recurrence.

2 investors

Bioelectrix develops patented wound electrodes that deliver gentle direct current to reactivate stalled healing while capturing real-time healing data, aiming to accelerate closure of hard-to-heal wounds. Its bioelectronic wound therapy initially targets diabetic foot ulcers and is intended for clinicians, payers, and existing healthcare wound care workflows.

1 investor

BIOEMTECH provides services and products to support preclinical research of drug candidates, aiming to speed their progress toward clinical translation. It serves the biotech and pharmaceutical research market.

1 investor

BioEsol provides industrial and commercial energy management software and Energy as a Service (EaaS) solutions, optimizing energy consumption and incorporating battery energy storage systems (BESS) for businesses seeking to reduce operational energy costs and carbon emissions.

1 investor

Bio Eutectics develops Natural Deep Eutectic Systems, bio-sourced solvents made from natural acids, amino acids, alcohols, and sugars to replace petrochemical solvents in industrial processes. It customizes these green chemistry solutions for manufacturers across industries seeking lower-toxicity, lower-volatility alternatives.

3 investors

BioFactura is a clinical-stage biopharmaceutical company developing biologics and biosimilars, and has launched Capitol Biologics, a CDMO division offering contract development and manufacturing services to advance biologics from concept to clinic.

0 investors

0 investors

BioFeyn is a life sciences company that applies biomedical nanoencapsulation technology (its "Feyn" delivery mechanism) to feed ingredients, improving nutrient absorption and bioavailability in animals. It focuses on aquaculture and agriculture, particularly salmon farming, serving farmers and feed suppliers while reducing waste and environmental impact.</parameter> <parameter name="founders">[{"full_name": "Timothy Bouley", "title": "CEO, Founder"}, {"full_name": "Marie-Christine Imbert", "title": "CSO, Founder"}]

2 investors

Biofidelity develops genomic biomarker testing technologies—its Aspyre and Enspyre products—for cancer detection, treatment selection, and minimal residual disease monitoring. The company serves oncology providers and patients with precision genomic diagnostics across the cancer patient journey.

3 investors

Biofine holds a patent portfolio for a technology that converts waste lignocellulosic feedstocks into renewable chemicals, carbon-negative biofuels, and biochar. The company operates a pilot plant in Maine and is developing its first commercial biorefinery in Lincoln, Maine, for the industrial bioeconomy.

0 investors

0 investors

Revolutionising the textile industry by pioneering a new era of plant-based alternatives to animal and synthetic derived materials

2 investors

0 investors